Serum Institute of India
30 Sep 2020
Last night, in a rare incident, Apple suffered from a major outage that left many of its services down, including Apple App Store, Music, Apple TV+, Photos, and iCloud.
27 Sep 2020
As India's COVID-19 vaccine strategy becomes a point of debate, Adar Poonawalla has expressed confidence over Prime Minister Narendra Modi's vision to protect Indian citizens from the ongoing pandemic.
22 Sep 2020
A vaccine for COVID-19 is likely to be ready by early 2021, a leading vaccine scientist has said. However, the real challenge for India would be conducting a vaccination drive for its population of 1.3 billion.
21 Sep 2020
As India's COVID-19 cases continue to surge by nearly a lakh every passing day, scientists are racing to get a vaccine ready as soon as possible.
16 Sep 2020
Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.
15 Sep 2020
Microsoft co-founder Bill Gates said that a vaccine for COVID-19 is critical and the herd immunity strategy cannot end the pandemic.
14 Sep 2020
Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing the vaccine for novel coronavirus, asserted that the vaccine will not be available for the entire world before the end of 2024.
12 Sep 2020
Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed.
12 Sep 2020
The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.
11 Sep 2020
Last night, multiple reports suggested that ByteDance is likely to miss the September 20 deadline for finalizing the sale of TikTok's US assets.
10 Sep 2020
A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.
10 Sep 2020
Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.
04 Sep 2020
As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.
30 Aug 2020
One of Bangladesh's largest drugmakers, Beximco Pharmaceuticals, has announced that it will invest in the Serum Institute of India (SII) for the development of a coronavirus vaccine.
27 Aug 2020
The global effort to develop a vaccine against the novel coronavirus SARS-CoV-2 continues as over 24 million people have been infected worldwide.
25 Aug 2020
The last week (August 17-22) was the worst one for India, as far as coronavirus cases and deaths are concerned, as the country added over 4.5 lakh cases to its tally and 6,666 deaths.
19 Aug 2020
In a major development, Adar Poonawalla's Serum Institute of India has started the Phase-2/3 trial of a promising COVID-19 vaccine licensed from AstraZeneca and Oxford University.
18 Aug 2020
Amid surging COVID-19 cases and questions over the peak for India, the government has started working towards procuring a vaccine.
15 Aug 2020
With the world counting on a coronavirus vaccine to save it from the disease that has taken 763,572 lives so far, Prime Minister Narendra Modi on Saturday said India is ready to mass-produce the vaccine once it's developed.
11 Aug 2020
India should have a vaccine to exit the COVID-19 pandemic by the end of this year.
07 Aug 2020
In a major development, the Serum Institute of India has confirmed that the price of its foreign-licensed COVID-19 vaccines will be capped at $3 per dose in low-to-middle-income nations.
06 Aug 2020
Serum Institute of India (SII) is set to source the COVID-19 vaccine developed by American biotech company Novavax.
04 Aug 2020
Ever since companies started developing vaccines for COVID-19, one big question has been on everyone's mind: how much the final, approved shot would cost to the public?
04 Aug 2020
In the updates since last night, Twitter drew flak for an error that restricted tweeting.
03 Aug 2020
A lot has happened over the weekend.
03 Aug 2020
The Serum Institute of India (SII) has gotten the approval to conduct phase 2 and 3 human clinical trials of the COVID-19 vaccine candidate developed by Oxford University.
30 Jul 2020
On January 30, television screens flashed reports of the first coronavirus patient in India - a student from Kerala who had returned from China's Wuhan.
30 Jul 2020
As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.
25 Jul 2020
Since the coronavirus outbreak started late last year, researchers have been racing to develop a vaccine against the virus, SARS-CoV-2.
24 Jul 2020
In the fight against COVID-19, or should we say the worst health crisis of our time, several institutes/organizations are racing to develop vaccines, anti-viral treatments.
22 Jul 2020
Adar Poonawalla, the chief of Serum Institute of India (SII), is hoping that vaccine to fight coronavirus will be available in India by the first quarter of 2021.
21 Jul 2020
The coronavirus vaccine, developed by researchers at Oxford University, could soon enter human trials phase in India, the CEO of Serum Institute of India informed on Monday.
17 Jul 2020
The COVID-19 vaccine developed by researchers at Oxford University in partnership with AstraZeneca generates an immune response against the infection in humans, The Telegraph reports.
05 Jul 2020
With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.
03 Jul 2020
India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.
26 Jun 2020
COVID-19 has wreaked havoc around the world, leaving everyone desperate for a vaccine - a much-needed shot that prevents contraction or at least mitigates the severe impact of the novel coronavirus.
07 Jun 2020
With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India.
26 Apr 2020
In a major development, Cyrus S. Poonawalla's Serum Institute of India has confirmed that it will start making a vaccine for COVID-19 next month.
26 Apr 2020
The total number of cases due to the coronavirus disease (COVID-19) surged past 26,000 in India on Saturday. Meanwhile, the death toll due to the viral disease rose to 824.
08 Apr 2020
The outbreak of coronavirus, and the ongoing nation-wide lockdown to prevent it from growing worse, has disrupted businesses so much that their leaders and investors are bleeding money.